Bioelectronics Corporation
BIEL
Rank in Stocks
#29610
BioElectronics Corporation, an electroceutical company, engages in the... BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
Share Price
$0.0003
Last synced: 2026-11-09
Market Cap
$7.41M
Change (1 day)
0.00%
Change (1 year)
-25.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioelectronics Corporation (BIEL)
Category
Healthcare
Operating Margin for Bioelectronics Corporation (BIEL)
Operating Margin as of November 2026 TTM: 15.91%
According to Bioelectronics Corporation's latest financial reports, its current operating margin (TTM) is 15.91%. At the end of 2025 the company had an operating margin of 15.91%.
Operating Margin history for Bioelectronics Corporation from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 15.91% | 0.00% |
| 2025 | 15.91% | -120.10% |
| 2024 | -79.17% | 106.28% |
| 2023 | -38.38% | -20.95% |
| 2022 | -48.55% | 405.73% |
| 2021 | -9.60% | -92.40% |
| 2020 | -126.26% | -10.68% |
| 2019 | -141.35% | -27.38% |
| 2018 | -194.64% | 152.39% |
| 2017 | -77.12% | 15.09% |
| 2016 | -67.01% | -12.24% |
| 2015 | -76.36% | -48.15% |
| 2014 | -147.28% | -48.33% |
| 2013 | -285.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -98.81% |
IE
|
|
| 10.95% | -99.31% |
CN
|
|
| 25.26% | -98.41% |
CH
|
|
| 13.54% | -99.15% |
CH
|
|
| 38.62% | -97.57% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioelectronics Corporation's operating margin
What is Bioelectronics Corporation's operating margin?
Bioelectronics Corporation's operating margin is 15.91%, as of Nov 2026.
What was Bioelectronics Corporation's operating margin in 2025?
In 2025, Bioelectronics Corporation's operating margin was 15.91%, compared with -79.17% in 2024.
How has Bioelectronics Corporation's operating margin changed since 2020?
From 2020 to 2025, Bioelectronics Corporation's operating margin was highest in 2025 (15.91%) and lowest in 2020 (-126.26%).
How does Bioelectronics Corporation's operating margin compare with similar companies?
Bioelectronics Corporation's operating margin (15.91%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.